Auditor27 Jul 2026, 06:20 pm
Oxygenta Pharma Appoints PCR & Associates as Cost Auditors
AI Summary
Oxygenta Pharmaceutical Ltd announced the appointment of M/s. PCR & Associates, Cost Accountants, as the company's Cost Auditors for the Financial Year 2026-27. This decision was approved by the Board of Directors during their meeting held on July 27, 2026. The board also approved the un-audited financial results for the quarter ended June 30, 2026, and the notice for the Annual General Meeting for FY 2025-26, scheduled for August 21, 2026. Additionally, the POSH Committee of the Board was re-constituted.
Key Highlights
- Oxygenta Pharma appointed PCR & Associates as Cost Auditors for FY 2026-27.
- Board approved un-audited Q1 FY27 financial results.
- Annual General Meeting for FY 2025-26 scheduled for August 21, 2026.
- POSH Committee of the Board has been re-constituted.
- Appointment of cost auditors is subject to shareholder ratification.
Price Impact
More from OXYGENTAPH